Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Jeanne Pimenta a Public Health Laboratory Service
Communicable Disease Surveillance, London NW9 5EQ, b National Screening
Committee, Institute of Health Sciences, Oxford OX3 7LF, c Evidence-Based Practice Centre,
St Catherine's Hospital, Birkenhead L42 0LQ, d Ella Gordon Unit, St
Mary's Hospital, Portsmouth PO3 6AD
Correspondence to: J
Pimenta JPimenta@phls.org.uk
| The first 150 words of the full text of this article appear below. |
Sexual and reproductive health in the United Kingdom urgently needs improving,1 and the government is developing the first integrated national strategy on sexual health. 2 3 Theoretical models describing the main determinants of the incidence of sexually transmitted infections suggest that reducing the mean duration of infectiousness is likely to lead to substantially lower levels of disease.4 One way of achieving such reductions is by the earlier ascertainment of cases through screening for infection. The chief medical officer's expert advisory group on Chlamydia trachomatis has recently evaluated the evidence for chlamydia screening in the United Kingdom.5 In this report we summarise the main evidence addressed by the group and outline how its conclusions have been implemented through a screening pilot in two health authorities in England.
| Table Removed (Available Only in the Full Text) |
| |
The problem |
|---|
C trachomatis infection is the most common curable,
bacterial, sexually transmitted infection in England.6
Since 1988, the number of cases seen in genitourinary medicine clinics
in
Read all Rapid Responses